Metabolic syndrome and the risk of preclinical heart failure: Insights after 17 years of follow-up from the STANISLAS Cohort.
Sign Up to like & getrecommendations! Published in 2022 at "Cardiology"
DOI: 10.1159/000523717
Abstract: Background We used data from participants initially free of clinical cardiovascular disease in the STANISLAS cohort to evaluate the association between metabolic syndrome (MS) and development of preclinical heart failure (HF). Methods and Results The… read more here.
Keywords: preclinical heart; risk preclinical; failure; metabolic syndrome ... See more keywords